RECRUITING

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

Talk to us

Conditions

Solid TumorHematological MalignancyWearable Electronic Devices

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.

Official Title

A Pilot Prospective Clinical Trial Using Remote Patient Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

Quick Facts

Study Start:2023-10-26
Study Completion:2025-11-26
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06106360

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Planned to be treated with a new cytotoxic chemotherapy or chemoimmunotherapy regimen for a solid tumor or malignant hematology condition for at least 4 months
  2. * ECOG performance status of 0-2
  3. * Age of 18 or older patient with any solid tumor or hematologic malignancy
  4. * English or Spanish speaker
  5. * Own an Apple iPhone
  6. * Capacity and willingness to provide informed consent
  1. * Patients undergoing concurrent radiation since they will be seen on a daily basis by clinic care teams and are not likely to benefit from active remote patient monitoring
  2. * Patients unwilling or unable to comply with the protocol, including wearing the Apple Watch (including recharging daily) and answering queries on the Locus Health iPhone application per the protocol and study group cadence
  3. * Any condition for which in the Investigator's opinion would limit compliance with study requirements

Contacts and Locations

Study Contact

Elahe Mollapour
CONTACT
(571) 472-4724
elahe.mollapour@inova.org
Keary Jane't
CONTACT
Keary.Janet@inova.org

Principal Investigator

John Deeken, MD
PRINCIPAL_INVESTIGATOR
Inova Schar Cancer Institute

Study Locations (Sites)

Inova Schar Cancer Institute
Fairfax, Virginia, 22031
United States

Collaborators and Investigators

Sponsor: Inova Health Care Services

  • John Deeken, MD, PRINCIPAL_INVESTIGATOR, Inova Schar Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-26
Study Completion Date2025-11-26

Study Record Updates

Study Start Date2023-10-26
Study Completion Date2025-11-26

Terms related to this study

Keywords Provided by Researchers

  • Wearable Electronic Devices

Additional Relevant MeSH Terms

  • Solid Tumor
  • Hematological Malignancy